Omar Al-Taweel
Cardiovascular Disease · Springfield, MONPI 1619428307
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Edwards Lifesciences at 26.7% of the total. Reporting peaked in 2023 at $5,754 and has fallen 64.2% since, to $2,058 in 2025.
Across 150 payments — averaging $98.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- Boston Scientific$2K
- Abbott$2K
- Penumbra, Inc.$1K
- Medtronic$1K
- Abiomed$1K
- plus $3K from 19 others
Across 1 payment — averaging $39.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$40
What the payments were for
- Grants$1,1218%
- Travel & lodging$4,18028%
- Food & beverage$8,41857%
- Education$8666%
- Gifts$1591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 30 | $3,937 |
| Boston Scientific | 20 | $2,074 |
| Abbott | 27 | $2,013 |
| Penumbra, Inc. | 7 | $1,491 |
| Medtronic | 9 | $1,053 |
| Abiomed | 10 | $1,039 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $644 |
| Cvrx, Inc. | 4 | $455 |
| Chiesi USA, Inc. | 3 | $231 |
| Astellas Pharma US Inc | 2 | $198 |
| Merck | 3 | $180 |
| Lantheus Medical Imaging, Inc. | 6 | $173 |
| Esperion Therapeutics, Inc. | 2 | $165 |
| E.r. Squibb & Sons, L.L.C. | 3 | $158 |
| Novo Nordisk | 2 | $149 |
| Cardiovascular Systems Inc. | 3 | $145 |
| Inari Medical, Inc. | 1 | $136 |
| Actelion Pharmaceuticals US, Inc. | 1 | $117 |
| Teleflex LLC | 1 | $107 |
| Heartflow, Inc. | 2 | $106 |
| Impulse Dynamics (USA) Inc. | 1 | $76 |
| Philips North America LLC | 1 | $39 |
| Livanova USA, Inc. | 1 | $35 |
| Novartis | 1 | $14 |
| Johnson & Johnson | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,331
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,202
- Impella$641
- ONYX FRONTIER$624
- SAPIEN 3 Ultra RESILIA$612
- Diamondback Coronary$484
- Barostim Neo System$455
- GENERAL ATHERECTOMY$349
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$240
- LifeVest$220
- ROTAPRO$170
- Ultreon$140
- ACIST RXI SYSTEM$140
- 3F$137
- FLOWTRIEVER CATHETER, S$136
- CT THROMBECTOMY SYSTEM KIT$136
- SYMPLICITY G3$127
- CARDIOMEMS$126
- Ozempic$125
- NEXLIZET$122
How this compares
$14,744 in reported general payments places this provider in the 80th percentile of 391 cardiovascular disease providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 23 | $184 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Springfield
- Keesag BaronSpringfield$15K
- Mikhail KosiborodKansas City$1.1M
- Georges ChahoudSaint Louis$937K
- William BowenSaint Louis$726K
- Daniel KellySaint Louis$582K
- John SpertusKansas City$360K
- James FairlambColumbia$342K
- James EllisonChesterfield$267K
- Osler Jay GuzonSaint Louis$211K
- Matthew FraleyFlorissant$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.